Bailard, Inc. Sangamo Therapeutics, Inc Transaction History

Bailard, Inc.

$3.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$7.29 - $10.97 $1.46 Million - $2.19 Million	-200,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $712,691 - $949,991	-79,100 Reduced 28.34%	200,000 $1.8 Million
Q2 2021 Aug 13, 2021	SELL	$10.17 - $12.64 $442,395 - $549,840	-43,500 Reduced 13.48%	279,100 $3.34 Million
Q1 2021 May 13, 2021	SELL	$10.88 - $17.05 $758,336 - $1.19 Million	-69,700 Reduced 17.77%	322,600 $4.04 Million
Q4 2020 Feb 03, 2021	BUY	$9.23 - $18.18 $204,906 - $403,596	22,200 Added 6.0%	392,300 $6.12 Million
Q3 2020 Nov 10, 2020	SELL	$9.38 - $12.48 $327,362 - $435,552	-34,900 Reduced 8.62%	370,100 $3.5 Million
Q2 2020 Aug 12, 2020	SELL	$6.21 - $11.83 $285,660 - $544,180	-46,000 Reduced 10.2%	405,000 $3.63 Million
Q1 2020 Apr 16, 2020	BUY	$5.05 - $8.85 $1.29 Million - $2.26 Million	255,900 Added 131.16%	451,000 $2.87 Million
Q4 2019 Jan 31, 2020	SELL	$8.03 - $11.7 $441,649 - $643,500	-55,000 Reduced 21.99%	195,100 $1.63 Million
Q3 2019 Oct 18, 2019	BUY	$9.05 - $12.22 $674,225 - $910,390	74,500 Added 42.43%	250,100 $2.26 Million
Q2 2019 Jul 26, 2019	BUY	$8.75 - $13.03 $170,625 - $254,085	19,500 Added 12.49%	175,600 $1.89 Million
Q1 2019 Apr 24, 2019	BUY	$7.72 - $12.81 $950,332 - $1.58 Million	123,100 Added 373.03%	156,100 $1.49 Million
Q4 2018 Feb 05, 2019	SELL	$9.51 - $16.6 $1.16 Million - $2.02 Million	-121,500 Reduced 78.64%	33,000 $379,000
Q3 2018 Nov 13, 2018	BUY	$13.05 - $19.05 $1 Million - $1.47 Million	77,000 Added 99.35%	154,500 $2.62 Million
Q2 2018 Aug 08, 2018	BUY	$13.9 - $19.8 $799,250 - $1.14 Million	57,500 Added 287.5%	77,500 $1.1 Million
Q1 2018 May 07, 2018	BUY	$16.7 - $26.35 $334,000 - $527,000	20,000 New	20,000 $380,000

Others Institutions Holding SGMO

# of Institutions

115

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$22.7 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.68 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.5 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.75 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account